Cargando…
miR-103 inhibits proliferation and sensitizes hemopoietic tumor cells for glucocorticoid-induced apoptosis
Glucocorticoid (GC) hormones are an important ingredient of leukemia therapy since they are potent inducers of lymphoid cell apoptosis. However, the development of GC resistance remains an obstacle in GC-based treatment. In the present investigation we found that miR-103 is upregulated in GC-sensiti...
Autores principales: | Kfir-Erenfeld, Shlomit, Haggiag, Noa, Biton, Moshe, Stepensky, Polina, Assayag-Asherie, Nathalie, Yefenof, Eitan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5352135/ https://www.ncbi.nlm.nih.gov/pubmed/27888798 http://dx.doi.org/10.18632/oncotarget.13447 |
Ejemplares similares
-
Preclinical evaluation and structural optimization of anti-BCMA CAR to target multiple myeloma
por: Harush, Ortal, et al.
Publicado: (2022) -
Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis
por: Sionov, Ronit Vogt, et al.
Publicado: (2006) -
A Role for Bcl-2 in Notch1-Dependent Transcription in Thymic Lymphoma Cells
por: Sionov, Ronit Vogt, et al.
Publicado: (2012) -
A human case of GIMAP6 deficiency: a novel primary immune deficiency
por: Shadur, Bella, et al.
Publicado: (2020) -
Development and manufacture of novel locally produced anti-BCMA CAR T cells for the treatment of relapsed/refractory multiple myeloma: results from a phase I clinical trial
por: Asherie, Nathalie, et al.
Publicado: (2022)